TNFSF4 and cancer: Similarly, another recent study by the same research team suggested that genetically engineered exosomes armed with not only CD3, EGFR but also the programmed death 1 and OX40 ligand (OX40L) obviously killed the EGFR-positive cancer cells and inhibited progression of established tumors[37].